TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2011

Phase II study of vorinostat for treatment of relapsed or refractory indolent non-Hodgkin's lymphoma and mantle cell lymphoma.

Mark Kirschbaum et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.